Lilly Launches Foundayo in the UK as NICE Review Continues
insidermonkey.com · 2026-09-05
Eli Lilly and Company (NYSE:LLY) has launched Foundayo in the United Kingdom, making Britain the first European country where the company’s oral treatment for weight management and type 2 diabetes is...
Read the full story at insidermonkey.com →
Is LLY undervalued? See TickrTrends' fair value analysis →